and nine months ended September 30, 2007, respectively. General and
administrative expenses included non-cash stock-based compensation
charges of $0.7 million and $1.6 million for the three and nine
months ended September 30, 2006, respectively.
DYNAVAX TECHNOLOGIES CORPORATION
RECONCILIATION OF GAAP REVENUES TO PRO FORMA REVENUES
(In thousands)
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
GAAP revenues $1,014 $1,592 $4,798 $2,409
ADD:
Collaboration funding incurred under
SDI programs 1,855 3,290 8,487 5,288
Pro forma revenues (1) $2,869 $4,882 $13,285 $7,697
(1) These pro forma amounts are intended to illustrate the Company's
revenues to be inclusive of collaboration funding provided for the
SDI programs. The collaboration funding is reflected in the amount
attributed to the noncontrolling interest in SDI in the Company's
consolidated statement of operations, but would have been reported as
revenue if SDI's results of operations were not consolidated with
those of the company. Management of the company believes the pro
forma results are a more useful measure of the Company's revenues
because it provides investors the ability to evaluate the Company's
operations in the manner that management uses to assess the continued
progress of programs funded under the SDI arrangement. These pro
forma results are not in accordance wit
'/>"/>
| SOURCE Dynavax Technologies Corporation Copyright©2007 PR Newswire. All rights reserved |